If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
not provided |
total |
81
|
46
|
1264
|
472
|
89
|
1
|
20
|
1901
|
Gene and significance breakdown #
Total genes and gene combinations: 40
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
not provided |
total |
KCNA5
|
6
|
1
|
296
|
137
|
22
|
0 |
0 |
429
|
KCNQ1
|
20
|
18
|
121
|
36
|
8
|
0 |
4
|
202
|
GJA5
|
6
|
0 |
135
|
61
|
4
|
0 |
0 |
198
|
SCN5A
|
20
|
10
|
156
|
11
|
4
|
0 |
10
|
198
|
MYL4
|
5
|
8
|
103
|
67
|
8
|
0 |
0 |
190
|
KCNJ2
|
3
|
2
|
112
|
7
|
16
|
0 |
2
|
139
|
SCN2B
|
2
|
0 |
71
|
55
|
4
|
0 |
0 |
130
|
LOC114827827, NPPA
|
1
|
0 |
78
|
47
|
4
|
0 |
0 |
128
|
GJA5, LOC122128420
|
2
|
0 |
44
|
15
|
1
|
0 |
0 |
62
|
ABCC9
|
2
|
0 |
49
|
8
|
0 |
0 |
1
|
60
|
KCNE2, LOC105372791
|
1
|
1
|
25
|
3
|
2
|
0 |
2
|
31
|
SCN1B
|
3
|
3
|
21
|
4
|
0 |
0 |
1
|
30
|
LOC110121269, SCN5A
|
1
|
1
|
24
|
1
|
1
|
0 |
0 |
28
|
KCNQ1, KCNQ1OT1
|
0 |
0 |
7
|
8
|
2
|
0 |
0 |
17
|
TTN
|
0 |
0 |
2
|
6
|
4
|
0 |
0 |
12
|
NPPA
|
1
|
0 |
1
|
4
|
1
|
0 |
0 |
7
|
NUP155
|
1
|
0 |
5
|
0 |
1
|
0 |
0 |
7
|
SCN3B
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
4
|
KCNJ2, LOC130061539
|
0 |
0 |
3
|
0 |
0 |
0 |
0 |
3
|
BAG3
|
0 |
0 |
0 |
0 |
2
|
0 |
0 |
2
|
HCN4
|
0 |
0 |
1
|
0 |
1
|
0 |
0 |
2
|
KCNA1, KCNA5
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
MYBPC3
|
0 |
0 |
1
|
1
|
0 |
0 |
0 |
2
|
SCN4B
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
ABCG4, ARCN1, ATP5MG, BCL9L, C2CD2L, CBL, CD3D, CD3E, CD3G, CENATAC, CXCR5, DDX6, DPAGT1, DRC12, FOXR1, H2AX, HINFP, HMBS, HYOU1, IFT46, JAML, KMT2A, MPZL2, MPZL3, NHERF4, NLRX1, PHLDB1, RPS25, SCN2B, SCN4B, SLC37A4, TMEM25, TRAPPC4, TREH, TTC36, UBE4A, UPK2, VPS11
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
AGTRAP, ANGPTL7, C1orf127, C1orf167, CASZ1, CLCN6, DISP3, DRAXIN, EXOSC10, FBXO2, FBXO44, FBXO6, MAD2L2, MASP2, MTHFR, MTOR, NPPA, SRM, TARDBP, UBIAD1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
AGTRAP, ANGPTL7, C1orf167, CLCN6, DISP3, DRAXIN, EXOSC10, FBXO2, FBXO44, FBXO6, KIAA2013, MAD2L2, MASP2, MTHFR, MTOR, NPPA, NPPB, PLOD1, SRM, TARDBP, UBIAD1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
AKAP9
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
ANK2
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
CORIN
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
KCNH2
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
LAMA4
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
LOC101927055, TTN
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
LOC126806430, TTN
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
LOC126861897, MHRT, MYH7
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
MIB1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
NEBL
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
PITX2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
SNTA1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
ZFHX3
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
not provided |
total |
Labcorp Genetics (formerly Invitae), Labcorp
|
6
|
7
|
651
|
366
|
40
|
0 |
0 |
1070
|
Fulgent Genetics, Fulgent Genetics
|
32
|
18
|
372
|
36
|
7
|
0 |
0 |
465
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
267
|
61
|
31
|
0 |
0 |
359
|
OMIM
|
41
|
0 |
0 |
0 |
0 |
1
|
0 |
42
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
2
|
1
|
21
|
0 |
0 |
0 |
0 |
24
|
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
|
0 |
1
|
3
|
7
|
10
|
0 |
0 |
21
|
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust
|
0 |
0 |
0 |
0 |
0 |
0 |
17
|
17
|
New York Genome Center
|
0 |
2
|
15
|
0 |
0 |
0 |
0 |
17
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
|
0 |
0 |
4
|
4
|
5
|
0 |
0 |
13
|
Baylor Genetics
|
3
|
1
|
8
|
0 |
0 |
0 |
0 |
12
|
Lildballe Lab, Aarhus University Hospital
|
0 |
5
|
1
|
1
|
0 |
0 |
0 |
7
|
Revvity Omics, Revvity
|
0 |
0 |
5
|
0 |
0 |
0 |
0 |
5
|
CSER _CC_NCGL, University of Washington
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
4
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
4
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
|
0 |
0 |
3
|
0 |
0 |
0 |
0 |
3
|
Blueprint Genetics
|
0 |
0 |
2
|
1
|
0 |
0 |
0 |
3
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
3
|
0 |
0 |
3
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
0 |
3
|
0 |
0 |
0 |
0 |
3
|
Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
3
|
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
|
0 |
0 |
0 |
1
|
1
|
0 |
0 |
2
|
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
2
|
Petrovsky National Research Centre of Surgery, The Federal Agency for Scientific Organizations
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
2
|
Phosphorus, Inc.
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
2
|
Clinical Genomics Laboratory, Stanford Medicine
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
MVZ Medizinische Genetik Mainz
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Institute of Human Genetics, University of Goettingen
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Centogene AG - the Rare Disease Company
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Courtagen Diagnostics Laboratory, Courtagen Life Sciences
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Mendelics
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
UCLA Clinical Genomics Center, UCLA
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Toronto General Hospital, University of Toronto
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
Génétique des Maladies du Développement, Hospices Civils de Lyon
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Pathophysiology of Heart Rhythm Disorders, Université Lyon 1 Claude Bernard
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Genetics Institute, Tel Aviv Sourasky Medical Center
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
3billion
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.